• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    ANI Pharmaceuticals, Inc. - Common Stock (NQ: ANIP )

    54.16 UNCHANGED
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 8
    Open 54.16
    Bid (Size) 48.00 (1)
    Ask (Size) 86.65 (2)
    Prev. Close 54.16
    Today's Range 54.16 - 54.16
    52wk Range 52.50 - 70.81
    Shares Outstanding 24,422,240
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Where ANI Pharmaceuticals Stands With Analysts
    Via Benzinga
    A Peek at ANI Pharmaceuticals's Future Earnings
    Via Benzinga

    Performance

    YTD
    -5.30%
    -5.30%
    1 Month
    -7.64%
    -7.64%
    3 Month
    -5.45%
    -5.45%
    6 Month
    -17.30%
    -17.30%
    1 Year
    -2.08%
    -2.08%

    More News

    Read More
    Critical Insights From ANI Pharmaceuticals Analyst Ratings: What You Need To Know
    Via Benzinga
    ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential
    Via Benzinga
    Peeling Back The Layers: Exploring ANI Pharmaceuticals Through Analyst Insights
    Via Benzinga
    In-Depth Examination Of 4 Analyst Recommendations For ANI Pharmaceuticals
    Via Benzinga
    This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
    Via Benzinga
    Evaluating ANI Pharmaceuticals: Insights From 5 Financial Analysts
    Via Benzinga
    Expert Outlook: ANI Pharmaceuticals Through The Eyes Of 4 Analysts
    Via Benzinga
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
    From ANI Pharmaceuticals, Inc. and Alimera Sciences, Inc.
    Via Business Wire
    ANIP Stock Earnings: ANI Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    ANI Pharmaceuticals's Earnings Outlook
    Via Benzinga
    Expert Ratings for ANI Pharmaceuticals
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), PlayAGS, Incorporated (NYSE - AGS), RBAZ Bancorp, Inc. (OTCPK - RBAZ)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
    Via InvestorPlace
    Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
    Via Benzinga
    ANIP Stock Earnings: ANI Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Alphabet, Dover And 2 Other Stocks Insiders Are Selling
    Via Benzinga
    Drug Maker Organon Stock Scores Relative Strength Upgrade
    Via Investor's Business Daily
    Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here's What You Need To Know
    Via Benzinga
    Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today?
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.